Nonetheless, they recommended that doctors be required to give permission to switch their patients' prescriptions to generic drugs. Gary Buehler, at the time the director of the FDA's office of generic drugs, said, "The only way you can somehow pin this down is to do a good study."
Nonetheless, they proposed that doctors should be required to approve switching their patients' medications to generics. Gary Buehler, who was in charge of the FDA's generic drugs office at the time, indicated, "The only way to guarantee this is through a comprehensive investigation."